Delivery Order SPE2DB20D3505-SPE2DB25FU7V6
Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,265.90 delivery order on July 18, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls, with completion scheduled for July 21, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,967.32 by the Defense Logistics Agency's Medical Supply Chain on June 25, 2025, for the supply of HUMIRA Pen 40mg/4ml in a quantity of two units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp received a competitive delivery order award from the Defense Logistics Agency (DLA) valued at $8,291.76 for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for immunological conditions. The contract is unclassified as a set-aside and carries a firm fixed-price structure with an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters, where...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, an injectable pharmaceutical product used to treat autoimmune conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,510.60 and is scheduled for completion by September 3, 2025. The contract represents a child order under DLA's broader pharmaceutical procurement framework, with the place...
- The Defense Logistics Agency awarded a $6,351.61 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for immunological treatment. This non-set-aside delivery order is expected to be completed by June 5, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,506.33 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, which is set to be completed by August 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $4,736.23 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 80 mg/0.8 mL pharmaceutical supplies on September 18, 2025, with completion targeted for September 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 7, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies, with a ceiling value of $9,205.12 and an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 12, 2025, for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL, a biologic pharmaceutical used to treat autoimmune conditions. This competitively awarded, non-set-aside delivery order carries a ceiling value of $11,239.33 under a firm fixed-price arrangement, with an ultimate completion date of September 15, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-aligned federal...